Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00025064
DRKS00025064
Completed
Not Applicable

Patients´preferences for systemic treatment of atopic dermatitis

Klinik für Dermatologie, Venerologie und Allergologie Universitätsmedizin Mannheim.0 sites194 target enrollmentApril 15, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsL20Atopic dermatitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
L20
Sponsor
Klinik für Dermatologie, Venerologie und Allergologie Universitätsmedizin Mannheim.
Enrollment
194
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

Participants attached great importance to safety and symptom control. However, preferences were also dependent on individual characteristics, underscoring the importance of personal counseling. Conjoined with medical considerations, patients' preferences have fundamental impact on shared decisions for treatment of atopic dermatitis.

Registry
who.int
Start Date
April 15, 2021
End Date
March 29, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Dermatologie, Venerologie und Allergologie Universitätsmedizin Mannheim.

Eligibility Criteria

Inclusion Criteria

  • •Presence of a medically diagnosed atopic dermatitis
  • •Age \= 18 years
  • •Consent to participate in the study

Exclusion Criteria

  • •Minority, lack of consent to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Study to Test a Computer-assisted Support System to Improve Patient-centered Care and Symptom Relief in Cancer PatientsCancerLymphomaLeukemiaStem Cell Transplantation
NCT00709813Oslo University Hospital145
Completed
Not Applicable
Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and PreferencesFabry DiseaseAnderson Fabry Disease
NCT04043273Amicus Therapeutics France SAS69
Completed
Not Applicable
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionMultiple Sclerosis, Relapsing-Remitting
NCT02598167Hoffmann-La Roche223
Completed
Not Applicable
Patient Satisfaction With the Management of a Stopped Pregnancy in the First TrimesterPregnancy Loss, Early
NCT05049980University Hospital, Toulouse52
Completed
Not Applicable
A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma of the BladderUrinary Bladder Neoplasms
NCT05742867Bristol-Myers Squibb115